Tag: Jim Hollingshead
Insulet appoints new CEO as Hollingshead steps down
May 1, 2025HME News Staff
ACTON, Mass. – Insulet has appointed Ashley McEvoy as president and CEO effective immediately.
She succeeds Jim Hollingshead, who has agreed to end his employment at the company and resign from its board of directors.
“Insulet continues to successfully deliver on its financial, clinical and operational objectives while advancing its mission to improve the lives of people with diabetes, and we are confident this leadership change will further the company’s...
ResMed Americas shines in fourth quarter
July 31, 2015Liz Beaulieu, Editor
SAN DIEGO - ResMed's flow generator sales increased 53% and mask sales rebounded to increase 5% in the fourth quarter ended June 30, 2015.ResMed officials credit healthcare informatics platforms like U-Sleep, which allows providers to monitor and manage their businesses, with powering the company to generate $151.5 million in flow generator sales for the quarter.“The analogy would be iTunes is such a great platform that people are buying a lot of iPhones and iPads,” said CEO Mick Farrell....
ResMed believes storm has now passed
January 24, 2014Liz Beaulieu, Editor
SAN DIEGO - Competitive bidding helped to drive down ResMed's revenues in the Americas by 2% for the second quarter ended Dec. 31, 2013, compared to the same period in 2012.Year-on-year, sales revenues from masks were flat and sales revenues from flow generators declined 5%, CEO Mick Farrell said during a Jan. 23 earnings call.“We were not satisfied with the results,” he said.Overall, ResMed reported revenues of $384.3 million for the quarter, a 2% increase. Net income was $86.6 million,...